Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T17:06:50.871Z.
Calculation as of: 2026-10-06T17:06:50.871Z.
Quote observation: 2026-10-06T17:05:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$4.40B
EBITDA Yield
11.37%
TTM Avg
8.95%
3Y Avg
6.39%
5Y Avg
6.78%
Market Cap
$4.42B
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.06B
EBITDA Yield
N/A
TTM Avg
12.18%
3Y Avg
9.94%
5Y Avg
9.94%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.27B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | 11.37% | 8.95% | 6.39% | 6.78% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.42B | N/A | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.15B | 6.14% | 6.89% | 5.07% | 4.64% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.06B | N/A | 12.18% | 9.94% | 9.94% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.03B | N/A | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 7.37% | 6.29% | 7.56% | 6.15% |
| BillionToOne, Inc. (BLLN)vs › | $4.63B | 1.32% | 0.79% | 0.79% | 0.79% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 7.15% | 7.73% | 6.77% | 5.88% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
